Skip to content

Safety Study of the Tetanus Vaccine (Pre-filled Syringe)

An observational study on the safety profile of the adsorbed tetanus vaccine (pre-filled syringe) in a post-marketing setting

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116533
Enrollment
Unknown
Registered
2026-01-12
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-neonatal tetanus

Interventions

Observation group(Patients who have received tetanus vaccine via adsorption therapy):None

Sponsors

Chengdu Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Patients aged 12 weeks and above who, according to the current “Diagnosis and Treatment Guidelines for Non-neonatal Tetanus” (2024 edition), require tetanus vaccination as determined by the attending physician and have voluntarily agreed to receive the investigational vaccine; 2) The subjects or their guardians agree to undergo the immunization schedule and related follow-up procedures specified in the protocol; 3) Consent has been obtained from the subjects or their guardians, and they have signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1) There are contraindications to vaccination stated in the vaccine instruction manual; 2) According to the researchers’ judgment, there are other factors that disqualify the individuals from participating in this study.

Design outcomes

Primary

MeasureTime frame
Incidence of Adverse Events/Reactions;

Countries

China

Contacts

Public ContactXiang Tao

Chengdu Third People's Hospital

1142752929@qq.com+86 13882132616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026